New York, NY – Harbor Healthcare Consultants, acting as the exclusive sell-side advisor, today announced the successful completion of the sale of The Healthy Choice Compounding Pharmacy, a New York-based non-sterile 503A compounding pharmacy. The transaction represents another successful closing for Harbor Healthcare Consultants in the growing anti-aging and wellness pharmacy sector.
The Healthy Choice Compounding Pharmacy has built a distinguished reputation for delivering high-quality compounded medications to patients and providers across the Northeast. All employees, operations, and the existing pharmacy location will remain intact following the closing, ensuring continuity of care and uninterrupted service for patients.
For the acquirer, a nationally accredited specialty compounding pharmacy headquartered in the Midwest, the acquisition meaningfully expands its geographic footprint and strengthens its growing network of patients and providers.
“We are proud to have represented The Healthy Choice in this transaction,” said Mark Alford of Harbor Healthcare Consultants. “This is an exceptional pharmacy — clinically strong, operationally sound, and supported by a team that is deeply committed to its patients and providers. Our goal from the outset was to find a buyer who shared those values and had the capabilities to help The Healthy Choice reach its full potential. We found exactly that, and we are excited to see what this partnership brings to the business and its clientele.”
“We are incredibly proud of what The Healthy Choice team has built,” said the Chief Executive Officer of The Healthy Choice Compounding Pharmacy. “Harbor Healthcare Consultants guided us through this process with professionalism and deep market expertise. Their ability to identify the right strategic partner gave us tremendous confidence throughout the transaction. We are grateful for their work and wish The Healthy Choice team continued success.”
About The Healthy Choice Compounding Pharmacy
The Healthy Choice Compounding Pharmacy is a New York-based specialty non-sterile compounding pharmacy providing customized pharmaceutical solutions to patients and prescribers across multiple states, committed to delivering high-quality compounded medications in full compliance with all applicable federal and state regulatory standards.
About Harbor Healthcare Consultants
Harbor Healthcare is a boutique M&A advisory firm offering advisory services to middle market healthcare organizations and specializing in compounding pharmacy since 1995. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, home infusion, compounding (503A and 503B) and 340B pharmacies. A pharmacist-founded firm comprised of bankers and healthcare entrepreneurs, Harbor offers unparalleled regulatory and advisory expertise while maintaining unshakeable business relationships with strategic, private equity and independent acquirers.
For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions